Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group-Reference-Cited by-同舟云学术

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

Published:2012-01-12 Issue: Volume:109 Page:22-29
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Grimm Peter,Billiet Ignace,Bostwick David,Dicker Adam P.,Frank Steven,Immerzeel Jos,Keyes Mira,Kupelian Patrick,Lee W. Robert,Machtens Stefan,Mayadev Jyoti,Moran Brian J.,Merrick Gregory,Millar Jeremy,Roach Mack,Stock Richard,Shinohara Katsuto,Scholz Mark,Weber Ed,Zietman Anthony,Zelefsky Michael,Wong Jason,Wentworth Stacy,Vera Robyn,Langley Stephen

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10827.x/fullpdf

Reference71 articles.

1. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;JAMA,1998

2. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer;Zelefsky;Urology,2001

3. National Comprehensive Cancer Network. Prostate Cancer treatment guidelines for patients 2007 http://www.psa-rising.com/download/nccnguidelines.pdf

4. No difference in 6 year biochemical failure rates with or without pelvic lymph nodes during radical prostatectomy in low-risk patients with prostate cancer;Bhatta;Urology,2004

5. Mayo Clinic validation of the d'Amico risk group classification for predicting survival following radical prostatectomy;Boorjian;J Urol,2008

Cited by 397 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer;Brachytherapy;2024-09

2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent;European Urology;2024-08

3. Dose Rate Effects from the 1950s through to the Era of FLASH;Radiation Research;2024-07-02

4. Outcomes of phosphorus-32 microparticle intratumoral implantation added to chemotherapy in patients with metastatic pancreatic adenocarcinoma;iGIE;2024-07

5. Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer;Current Urology Reports;2024-06-11